• Explore /
  • Poster
  • / Anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with metastatic castration-resistant prostate cancer.

Anti-tumor activity of RP12146, a PARP1/2 inhibitor, in patients with metastatic castration-resistant prostate cancer.

Abstract Poster

Authors

Piotr Wysocki

Piotr Jan Wysocki

Jagiellonian University-Medical College, Krakow, Poland

Piotr Jan Wysocki , Maciej Tadeusz Lubaś , Mateusz Łobacz, , Ewa Kalinka , Piotr Tomczak , Michal Kwiatek , Iwona A. Lugowska , Dominik Chraniuk , Prajak J. Barde , Swaroop V.S. Vakkalanka , Martin Smakal

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT05002868

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 154)

DOI

10.1200/JCO.2024.42.4_suppl.154

Abstract #

154

Poster Bd #

G4

Abstract Disclosures

Similar Posters

First Author: Piotr Jan Wysocki

First Author: Benedito A. Carneiro

First Author: Johann S. De Bono

First Author: Daniel Triner